Free Trial

Nature's Sunshine Products, Inc. (NASDAQ:NATR) Short Interest Up 23.3% in March

Nature's Sunshine Products logo with Medical background
Remove Ads

Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) was the target of a significant increase in short interest in March. As of March 15th, there was short interest totalling 74,000 shares, an increase of 23.3% from the February 28th total of 60,000 shares. Based on an average daily trading volume, of 31,700 shares, the days-to-cover ratio is currently 2.3 days. Approximately 0.5% of the company's stock are sold short.

Institutional Trading of Nature's Sunshine Products

Institutional investors have recently made changes to their positions in the business. Dimensional Fund Advisors LP raised its holdings in Nature's Sunshine Products by 3.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 856,701 shares of the company's stock worth $12,560,000 after acquiring an additional 30,464 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Nature's Sunshine Products by 3.6% during the 4th quarter. Renaissance Technologies LLC now owns 542,297 shares of the company's stock worth $7,950,000 after purchasing an additional 18,800 shares during the last quarter. Kennedy Capital Management LLC raised its stake in shares of Nature's Sunshine Products by 2.9% during the 4th quarter. Kennedy Capital Management LLC now owns 409,964 shares of the company's stock worth $6,010,000 after purchasing an additional 11,646 shares in the last quarter. American Century Companies Inc. boosted its holdings in shares of Nature's Sunshine Products by 2.7% in the 4th quarter. American Century Companies Inc. now owns 304,432 shares of the company's stock valued at $4,463,000 after buying an additional 8,085 shares during the last quarter. Finally, Northern Trust Corp grew its stake in shares of Nature's Sunshine Products by 2.7% in the fourth quarter. Northern Trust Corp now owns 119,005 shares of the company's stock valued at $1,745,000 after buying an additional 3,174 shares in the last quarter. Institutional investors own 79.40% of the company's stock.

Remove Ads

Nature's Sunshine Products Stock Performance

NASDAQ NATR traded down $0.29 during trading on Friday, hitting $11.78. The stock had a trading volume of 77,436 shares, compared to its average volume of 47,305. Nature's Sunshine Products has a 12 month low of $10.81 and a 12 month high of $20.01. The company's 50-day moving average price is $13.81 and its two-hundred day moving average price is $14.27. The company has a market capitalization of $217.74 million, a PE ratio of 13.39 and a beta of 0.91.

Nature's Sunshine Products Company Profile

(Get Free Report)

Nature's Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

Featured Stories

Should You Invest $1,000 in Nature's Sunshine Products Right Now?

Before you consider Nature's Sunshine Products, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.

While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Stocks to Buy on the Dip—and 3 to Dump Fast
Trump Tariffs Tumble the Stock Market—Here’s How to Protect Your Money
Donald Trump Owns These 7 Stocks, Should You?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads